reports
Winmark Corp: 1 director
A director at Winmark Corp sold 3,021 shares at 425.488USD and the significance rating of the trade was 89/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
The Broken Coast Difference: Tilray Brands’ Broken Coast Craft Cannabi...
The Broken Coast Difference: Tilray Brands’ Broken Coast Craft Cannabis Introduces New Premium Strain ‘Platinum Pavé’ TORONTO, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading lifestyle and consumer packaged goods company, is thrilled to announce the latest small batch indica strain by premium craft cannabis brand, : Platinum Pavé. This exceptional new cultivar is one of the first from Broken Coast's state-of-the-art Vancouver Island, BC facility. Platinum Pavé is meticulously grown under optimized conditions in single-strain, laborator...
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia ...
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension) Amglidia® has been approved by the European Medicines Agency (EMA) and is commercially available in EuropeStrong strategic fit with Eton’s existing pediatric endocrinology focusAmglidia has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA)Potential New Drug Application (NDA) submission in 2026 DEER PARK, Ill., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on ...
Redhook Brewery and Montlake Futures Team Up to Launch Montlake Gameda...
Redhook Brewery and Montlake Futures Team Up to Launch Montlake Gameday Gold Lager, a New Craft Beer in Support of University of Washington Athletes SEATTLE, Nov. 21, 2024 (GLOBE NEWSWIRE) -- (“Redhook”), Seattle’s pioneering craft brewery and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), officially presents their new partnership with the , supporting student-athletes at the University of Washington (UW). Together, they launched Montlake Gameday Gold Lager, the Official Beer of the Montlake Futures NIL Collective. This unique lager stands out as the only beer dedicate...
Tilray Brands Unveils 2024 Holiday Cannabis Gift Guide
Tilray Brands Unveils 2024 Holiday Cannabis Gift Guide Indulge in Premium Chocolate Edibles, Cannabis-Infused Drinks, New Pre-Rolls, and Top-Quality Flower - the Perfect Selection for Cannabis Connoisseurs this Festive Season! TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading lifestyle and consumer packaged goods company, is excited to announce the launch of its 2024 Holiday Cannabis Gift Guide. The guide features a handpicked selection of cannabis products that are perfect for the festive season. With offerings from Tilray's ...
Tilray Brands Gets Festive with its 2024 Holiday Beverage Gift Guide
Tilray Brands Gets Festive with its 2024 Holiday Beverage Gift Guide Explore Award-Winning Craft Beers, Premium Spirits, Sparkling Water, Non-Alcoholic Brews, and New Hemp-Derived THC Drinks Discover the Best Craft Brews from Across the U.S. at Tilray's Festive Holiday Brewpub Events NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, is pleased to present its 2024 holiday spirits and craft beverage gift guide, full of unique gift ideas for your loved ones. This curated selection featu...
Tilray Medical lance ses premiers produits commerciaux à base de canna...
Tilray Medical lance ses premiers produits commerciaux à base de cannabis thérapeutique « cultivés en Allemagne » dans le cadre de son autorisation de culture récemment étendue NEUMÜNSTER, Allemagne, 14 nov. 2024 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc. (« Tilray Brands ») (NASDAQ : TLRY et TSX : TLRY) et un leader mondial du cannabis thérapeutique qui permet aux patients et aux professionnels de la santé de prendre ensemble des décisions de santé individualisées éclairées, a annoncé aujourd’hui le lancement de ses premières fleurs de cannabis thérapeutique ...
Tilray Medical bringt erste in Deutschland angebaute kommerzielle medi...
Tilray Medical bringt erste in Deutschland angebaute kommerzielle medizinische Cannabisprodukte unter neu erweiterter Anbaulizenz auf den Markt NEUMÜNSTER, Deutschland, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. („Tilray Brands“) (NASDAQ: TLRY und TSX: TLRY) und ein weltweit führender Anbieter von medizinischem Cannabis, der die therapeutische Allianz zwischen Patienten und medizinischen Fachkräften stärkt, um fundierte, individuelle Gesundheitsentscheidungen zu treffen, hat heute die Markteinführung seiner ersten kommerziellen, in Deuts...
Blue Point Brewery Expands Winter Seasonal Lineup with Blitz Beer Amer...
Blue Point Brewery Expands Winter Seasonal Lineup with Blitz Beer American Lager and Hosts The Blue Point Blitz Celebration at Webster Hall NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- , Long Island’s original craft brewery and a subsidiary of Tilray Brands (NASDAQ: TLRY and TSX: TLRY), proudly announces Blitz Beer, a refreshing new American Lager added to Blue Point’s winter seasonal lineup. Available November through February, Blitz Beer offers a crisp, sessionable profile perfect for colder months and festive gatherings. New York has a rich tradition of brewing exceptional American l...
Tilray Medical Launches its First Commercial “Grown in Germany” Medica...
Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License NEUMÜNSTER, Germany, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced the launch of its first commercial German grown medical cannabis flowers from its Aphria RX GmbH (“Aphria RX”) facility...
Get Ready for Winter with 10 Barrel’s 13th Annual Pray for Snow Party
Get Ready for Winter with 10 Barrel’s 13th Annual Pray for Snow Party Join 10 Barrel Brewing for a Free Community Event Celebrating the Snowboard Season with Live Music, Giveaways, and the Premiere of the "Beer Lodge" film at 10 Barrel’s Winter Party BEND, Ore., Nov. 13, 2024 (GLOBE NEWSWIRE) -- . (“10 Barrel Brewing” or “10 Barrel”), a pioneering craft brewery and subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is excited to announce the , a free, all-ages event celebrating the festivities of the winter season, community, and of course, great beer. The event will take ...
Breckenridge Distillery's Latest Creation is the Perfect Addition to Y...
Breckenridge Distillery's Latest Creation is the Perfect Addition to Your Holiday Bar: Breckenridge Candy Cane Vodka BRECKENRIDGE, Colo., Nov. 13, 2024 (GLOBE NEWSWIRE) -- , one of the most-awarded craft distilleries in the U.S., and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), releases its new for the holiday season. Whether enjoyed neat, on the rocks, or as the star ingredient of a favorite holiday cocktail, Breckenridge Distillery’s Candy Cane Vodka brings holiday cheer to those aged 21 and up and is now available in retailers nationwide. is 80 proof / 40% ABV...
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results Reported total revenue of $10.3 million and GAAP Net Income of $0.6 million, or $0.02 per diluted shareEntered into an asset purchase agreement to acquire Increlex® (mecasermin injection)Q3 2024 product sales increased 40% over Q3 2023, representing 15th straight quarter of sequential product sales growthProduced positive quarterly GAAP net income from product sales for first time in company historyGenerated cash from operations of $2.9 million in Q3 2024Granted additional patent for ET-400Management to hold conference call t...
Experience the Ultimate 420 Festival Celebration with SweetWater's 20t...
Experience the Ultimate 420 Festival Celebration with SweetWater's 20th Anniversary Lineup Featuring The Revivalists, Marcus King Band, Greensky Bluegrass, Drive-By Truckers and Cypress Hill at Atlanta's Iconic Pullman Yards from April 18-20, 2025 ATLANTA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- , (“SweetWater Brewing” or “SweetWater”), the hottest craft brewer in Atlanta and the largest in the Southeast, a subsidiary of Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY), has unveiled the headliners for the 2025 , marking the festival’s 20th anniversary with an epic celebration of music, cultur...
Tilray Medical gibt positive Ergebnisse einer Studie zu oralem Cannabi...
Tilray Medical gibt positive Ergebnisse einer Studie zu oralem Cannabisextrakt bei durch Chemotherapie induziertem Erbrechen bekannt SYDNEY, Australien, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. („Tilray Brands“) (NASDAQ: TLRY und TSX: TLRY) und ein weltweit führender Anbieter von medizinischem Cannabis, der die therapeutische Allianz zwischen Patienten und Ärzten stärkt, um informierte, individuelle Gesundheitsentscheidungen zu treffen, freut sich, die Endergebnisse einer neuen wissenschaftlichen Studie mit dem Titel „Oral Cannabis Ext...
Tilray Medical annonce les résultats positifs d’une étude sur l’extrai...
Tilray Medical annonce les résultats positifs d’une étude sur l’extrait de cannabis oral dans le traitement des vomissements induits par la chimiothérapie SYDNEY, Australie, 07 nov. 2024 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc., ci-après « Tilray Brands » (NASDAQ : TLRY et TSX : TLRY) et leader mondial du cannabis thérapeutique, qui permet aux patients et aux professionnels de la santé de prendre ensemble des décisions de santé individualisées éclairées, se réjouit d’annoncer les conclusions finales de la nouvelle étude scientifique conduite par son équipe i...
Tilray Launches "Men's Health on Tap" Podcast: Acclaimed Doctors Engag...
Tilray Launches "Men's Health on Tap" Podcast: Acclaimed Doctors Engage in Empowering Discussions and Break Down Stigmas Around Men's Health Topics NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a lifestyle and consumer packaged goods company, announces the launch of "Men's Health on Tap," a new podcast series hosted by distinguished doctors, Dr. John P. Sfakianos, MD, Associate Professor, Department of Urology at the Icahn School of Medicine, and Dr. Steven A. Kaplan, MD, Professor, Department of Urology at the Icahn School of Medicine. The ...
Tilray Medical Announces Positive Results from Study on Oral Cannabis ...
Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis SYDNEY, Australia, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, is pleased to announce the final results of a new scientific study their team has supported titled, "Oral Cannabis Extract for Secondary Prevention of Chemotherapy...
Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone ...
Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution) - Product has patent protection through 2043 -- Prescription Drug User Fee Act (PDUFA) target action date of February 28, 2025 - DEER PARK, Ill., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that the United States Patent and Trademark Office (USPTO) has granted the Company U.S. Patent Application No. 18/443,889, now U.S. Pa...
Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on...
Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 DEER PARK, Ill., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the "Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report third quarter 2024 financial results on Tuesday, November 12, 2024. Management will host a conference call and live audio webcast to discuss the results at 4:30 p.m. ET (3:30 p.m. CT). Dial in (Audio Only) Toll-free: 888-596-4144 N...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.